Telemedicine and e-Health Solutions for COVID-19: Patients' Perspective

Pappot, Nina; Taarnhøj, Gry Assam; Pappot, Helle

doi:10.1089/tmj.2020.0099

Cited by 88 publications

(64 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Telemedicine and virtual software platforms are practically feasible and appropriate for the support of medical practitioners and patients during and after this pandemic via synchronous and asynchronous mediums such as smartphone application, telephone, videoconference, and e-mail [26]. Although the adoption of telemedicine and virtual software platforms holds promise for managing pandemic response, its adoption has limitations such as the availability of robust IT infrastructure, licensing and regulatory services, equipment costs, training of both physicians and nurses, and alterations to integrate within current hospital workflows [3,15,27]. Among others, ethical considerations must be taken into account [5].…”

Section: Factors That Impact Adoption Of Telemedicine and Virtual Sofmentioning

confidence: 99%

Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic

2020

View full text Add to dashboard Cite

As the novel coronavirus disease 2019 (COVID-19) continues to spread across countries, the need for innovative measures to provide high-quality patient care and manage its spread has become more imperative. Software-based systems such as medical software applications could provide valuable suggestion on health-related information to physicians towards improving quality of life, especially for outpatients (e.g., elderly, immunosuppressed, pregnant women). The use of telemedicine and virtual software offers promising potential in the fight against COVID-19. Accordingly, by means of expedited literature and document review, this paper provides implication on the opportunities, application, and challenges of telemedicine and existing virtual software currently adopted as suitable initiatives for reducing the spread of COVID-19. More importantly, findings present factors that impact adoption of telemedicine. The findings suggest that telemedicine and virtual software are capable of decreasing emergency room visits, safeguarding healthcare resources, and lessening the spread of COVID-19 by remotely treating patients during and after the COVID-19 pandemic.

show abstract

Section: Factors That Impact Adoption Of Telemedicine and Virtual Sofmentioning

confidence: 99%

Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic

2020

View full text Add to dashboard Cite

show abstract

“…Disabilities and technology illiteracy pose a major obstacle to access 219,220 . Social aspects of traditional medical approaches are lost with telemedicine, and this may be a significant problem for some categories of psychiatric patients 221 .…”

Section: Telemedicine During the Covid-19 Pandemicmentioning

confidence: 99%

Adaptation of evidence‐based suicide prevention strategies during and after theCOVID‐19 pandemic

et al. 2020

View full text Add to dashboard Cite

Suicide is preventable. Nevertheless, each year 800,000 people die of suicide in the world. While there is evidence indicating that suicide rates de‐crease during times of crises, they are expected to increase once the immediate crisis has passed. The COVID‐19 pandemic affects risk and pro‐tective factors for suicide at each level of the socio‐ecological model. Economic downturn, augmented barriers to accessing health care, increased access to suicidal means, inappropriate media reporting at the societal level; deprioritization of mental health and preventive activities at the community level; interpersonal conflicts, neglect and violence at the relationship level; unemployment, poverty, loneliness and hopelessness at the individual level: all these variables contribute to an increase of depression, anxiety, post‐traumatic stress disorder, harmful use of alcohol, substance abuse, and ultimately suicide risk. Suicide should be prevented by strengthening universal strategies directed to the entire population, including mitigation of unemployment, poverty and inequalities; prioritization of access to mental health care; responsible media reporting, with information about available support; prevention of increased alcohol intake; and restriction of access to lethal means of suicide. Selective interventions should continue to target known vulnerable groups who are socio‐economically disadvantaged, but also new ones such as first responders and health care staff, and the bereaved by COVID‐19 who have been deprived of the final contact with loved ones and funerals. Indicated preventive strategies targeting individuals who display suicidal behaviour should focus on available pharmacological and psychological treatments of mental disorders, ensuring proper follow‐up and chain of care by increased use of telemedicine and other digital means. The scientific community, health care professionals, politicians and decision‐makers will find in this paper a systematic description of the effects of the pandemic on suicide risk at the society, community, family and individual levels, and an overview of how evidence‐based suicide preventive interventions should be adapted. Research is needed to investigate which adaptations are effective and in which con‐texts.

show abstract

“…This topic has gained momentum during the COVID-19 pandemic. 22,23 Patients who need medical attention can reach the system via phone. In this way, a health care provider could appropriately triage the patients to urgent imaging/laboratory work or hospitalization if needed and assure that the facilities are taking extensive precautions to prevent overload in the ERs.…”

Section: Complicated Ureteral Stones During Covid-19 Eramentioning

confidence: 99%

The Increased Risk of Complicated Ureteral Stones in the Era of COVID-19 Pandemic

Gül

Kaynar

Yi̇ldi̇z

et al. 2020

Journal of Endourology

View full text Add to dashboard Cite

Background: Ureteral stone disease may be an emergent condition if the appropriate management is not performed in a timely manner. As the coronavirus disease 2019 (COVID-19) continues to spread globally, isolation and restriction orders taken by the governments have become the cores to control the pandemic. In this study, we, therefore, aimed to investigate the ureteral stone presentations in a high-volume university hospital during the COVID-19 restriction order period. Materials and Methods: The data of 149 patients who were hospitalized due to ureteral stone both during the COVID-19 pandemic restriction period and the corresponding period (non-COVID-19) of the previous year were collected and analyzed retrospectively. Unpaired Student's t-test was used to compare continuous variables. The categorical data were assessed using Chi-square and Fisher's exact tests. Results: Of 149 patients, 35 were hospitalized in the COVID-19 restrictions period. While the mean age and the stone characteristics of the two groups did not differ significantly, serum creatinine levels (1.9-1.85 vs 1.15-0.64) and the white blood cell counts (12.45-6.54 vs 8.21-4.15) at hospital admission were significantly higher in the COVID-19 restrictions group (p = 0.034 and p = 0.005, respectively). According to the priority classification recommendations of the European Urology Guidelines Office Rapid Reaction Group for urolithiasis applicable during the COVID-19 pandemic, a significant difference was observed between the two periods (X 2 = 9.907, p = 0.019). In particular, the rate of emergency cases was found more than threefold in the COVID-19 period. Although there was no significant difference in terms of the grade of hydronephrosis at hospital admission between the two groups, the rates of grade 3 and 4 hydronephrosis were higher in the COVID-period group (1.8-and 3.3-fold, respectively). Conclusion: The rate of complicated ureteral stone disease significantly increased during the COVID-19 restrictions period. Urologists should prioritize the patients most in need of urgent care during COVID-19-like biosocial crisis.

show abstract

Telemedicine and e-Health Solutions for COVID-19: Patients' Perspective

Cited by 88 publications

References 6 publications

Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic

Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic

Adaptation of evidence‐based suicide prevention strategies during and after theCOVID‐19 pandemic

The Increased Risk of Complicated Ureteral Stones in the Era of COVID-19 Pandemic

Contact Info

Product

Resources

About